Atrial fibrillation in organ transplant recipients: only a marker of the underlying disease?
- 15 Downloads
Despite good progress in the management of patients with atrial fibrillation (AF), this dysrhythmia remains one of the major causes of cardiovascular morbidity and mortality in the world [1, 2, 3, 4, 5]. In the general population, the number of patients with AF is predicted to rise steeply in the coming years: the increase in AF prevalence can be attributed both to better detection of silent AF alongside increasing age and conditions predisposing to it [6, 7, 8]. But AF is not just a problem of the general population: in the critically ill, this dysrhythmia is gaining increasing attention, because it represents a frequent complication (reported incidence from 5 to 15% in different studies), and its presence is associated with an increased mortality, as well as with a longer stay in the Intensive Care Unit . Risk factors include advanced age, white race, high severity scores, presence of organ failures and sepsis. This situation underlines the need to prevent and treat patients with...
Compliance with ethical standards
Conflict of interest
The authors have no conflict of interest to declare.
Statement of human and animal rights
The study protocol was approved by the local Ethics Committee.
All subjects provided oral and written informed consent.
- 11.Andersson T, Magnuson A, Bryngelsson IL et al (2014) Gender-related differences in risk of cardiovascular morbidity and all-cause mortality in patients hospitalized with incident atrial fibrillation without concomitant diseases: a nationwide cohort study of 9519 patients. Int J Cardiol 177:91–99CrossRefGoogle Scholar